Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Endometrial Carcinoma”

173 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 173 results

Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00004082
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Study completedNCT00814086
What this trial is testing

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more
Gynecologic Oncology Group 23
Testing effectiveness (Phase 2)Study completedNCT00064025
What this trial is testing

Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation+5 more
Gynecologic Oncology Group 75
Large-scale testing (Phase 3)Looking for participantsNCT05256225
What this trial is testing

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Who this might be right for
Endometrial CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+5 more
National Cancer Institute (NCI) 360
Not applicableStudy completedNCT01164735
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage III Uterine Corpus CancerStage IV Uterine Corpus Cancer
Gynecologic Oncology Group 169
Not applicableLooking for participantsNCT04504006
What this trial is testing

European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III

Who this might be right for
Endometrial Cancer
Dr. Paul Buderath 500
Large-scale testing (Phase 3)Study completedNCT00002706
What this trial is testing

Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus

Who this might be right for
Endometrial AdenocarcinomaStage I Uterine Corpus CancerStage I Uterine Sarcoma+2 more
Gynecologic Oncology Group 2,616
Testing effectiveness (Phase 2)Study completedNCT00006005
What this trial is testing

Thalidomide in Treating Patients With Gynecologic Sarcomas

Who this might be right for
Endometrial CancerSarcoma
New York University Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00002641
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 350
Large-scale testing (Phase 3)Study completedNCT00002920
What this trial is testing

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Who this might be right for
Breast CancerEndometrial Cancer
SWOG Cancer Research Network 313
Large-scale testing (Phase 3)Study completedNCT00002459
What this trial is testing

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus

Who this might be right for
Endometrial CancerSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 224
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Active Not RecruitingNCT04214067
What this trial is testing

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Who this might be right for
Endometrial Endometrioid AdenocarcinomaStage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
National Cancer Institute (NCI) 164
Large-scale testing (Phase 3)Ended earlyNCT00016341
What this trial is testing

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Not applicableLooking for participantsNCT03621904
What this trial is testing

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer Stage IIIEndometrial Cancer Stage IVEndometrial Cancer Recurrent
Radboud University Medical Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT05564377
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+12 more
National Cancer Institute (NCI) 2,900
Very early researchLooking for participantsNCT05691010
What this trial is testing

Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Who this might be right for
Endometrial CancerStage III Endometrial CancerStage III Endometrial Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 28
Early research (Phase 1)Study completedNCT00003704
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Who this might be right for
Cancer
Alliance for Clinical Trials in Oncology 51
Next Page